Unleash Immuno Oncolytics
Manufacturing · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
640 Axminister Dr, Fenton, Missouri, 630...Website
unleash.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Unleash Immuno Oncolytics
Unleash Immuno Oncolytics is an immune-oncology company focused on developing armed, oncolytic viruses that target both tumor cells and the surrounding stromal compartment in cancer treatment. Their lead product, UIO-524, is designed to disrupt tumor architecture and enhance the immune response against malignant cells. The company addresses the challenges of treating metastatic disease by utilizing conditionally replicating viruses that can selectively infect and replicate within both tumor and stroma cells. Their innovative approach aims to unleash the body's natural ability to eliminate cancer through a systemic immune response.Explore more
Unleash Immuno Oncolytics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Unleash Immuno Oncolytics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Unleash Immuno Oncolytics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Unleash Immuno Oncolytics had a recent Job posting/layoffs
Check if Unleash Immuno Oncolytics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Unleash Immuno Oncolytics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Unleash Immuno Oncolytics recently announced quarterly report
Check out if Unleash Immuno Oncolytics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Unleash Immuno Oncolytics
Funding: Get notified immidiatlly once Unleash Immuno Oncolytics has new funding data
Recommended Actions
Find VP level buyers at Unleash Immuno Oncolytics
Find more new buyers
Compare Similar Companies to Unleash Immuno Oncolytics
Compare insights from companies similar to Unleash Immuno Oncolytics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Unleash Immuno Oncolytics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Unleash Immuno Oncolytics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Unleash Immuno Oncolytics.
Unleash Immuno Oncolytics Tech Stack
A closer look at the technologies used by Unleash Immuno Oncolytics
Unleash Immuno Oncolytics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Unleash Immuno Oncolytics
Sign Up For FreeTo access detailed company insights
Unleash Immuno Oncolytics is an immune-oncology company focused on developing armed, oncolytic viruses that target both tumor cells and the surrounding stromal compartment in cancer treatment. Their lead product, UIO-524, is designed to disrupt tumor architecture and enhance the immune response against malignant cells. The company addresses the cha... Read More
